An unusual case of asymptomatic non-urothelial bladder tumour

被引:1
|
作者
Ching, Daniel [1 ]
Anastasiadis, Eleni [2 ]
Sandhu, Sarb [2 ]
机构
[1] Fiona Stanley Hosp, Murdoch, WA, Australia
[2] Kingston Hosp NHS Fdn Trust, Dept Urol, Kingston Upon Thames, Surrey, England
来源
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS | 2016年 / 27卷
关键词
Urinary bladder neoplasms; Non-urothelial bladder tumour; Paraganglioma; Extra-adrenal; Cystoscopy and transurethral resection; Case report;
D O I
10.1016/j.ijscr.2016.07.008
中图分类号
R61 [外科手术学];
学科分类号
摘要
INTRODUCTION: Non-urothelial tumours are rare and account for less than 5% of all bladder tumours. Bladder paragangliomas also known as extra-adrenal pheochromocytomas are of the non-urothelial subgroup. We present an unusual case of asymptomatic bladder paraganglioma. CASE REPORT: A 77 year old lady presented with acute abdominal pain was found to have an incidental enhancing nodule in the bladder. During cystoscopy and transurethral resection the patient experienced significant fluctuations in blood pressure that required anaesthetic adjustments. Review of histology confirmed a diagnosis of bladder paraganglioma. DISCUSSION: Most bladder paraganglioma cases present with sympathomimetic related symptoms and microscopic haematuria but our patient was asymptomatic which resulted in inadequate pre-operative optimisation and high anaesthetic risk. Majority of paragangliomas are benign but there is a 20-40% chance of malignancy. The management options will predominantly depend on whether disease is localised, regional, metastatic or recurrent in nature. CONCLUSION: Due to the non-specific nature of disease, variability of presentations and rare incidence, bladder paragangliomas are often not part of the urologists' differential diagnoses. In our opinion, establishing guidelines should assist to achieve a balance between anaesthetic risks, cystoscopy and follow up. (C) 2016 Published by Elsevier Ltd on behalf of US Publishing Group Ltd.
引用
收藏
页码:18 / 20
页数:3
相关论文
共 50 条
  • [31] The use of Urovysion™ fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder
    Reid-Nicholson, Michelle D.
    Ramalingam, Preetha
    Adeagbo, Bamidele
    Cheng, Ningli
    Peiper, Stephen C.
    Terris, Martha K.
    MODERN PATHOLOGY, 2009, 22 (01) : 119 - 127
  • [32] Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current Development
    Kwon, Whi-An
    Seo, Ho Kyung
    Song, Geehyun
    Lee, Min-Kyung
    Park, Weon Seo
    BIOMEDICINES, 2025, 13 (01)
  • [33] Genetic alterations detected by FISH (UroVysion™ probe set) in non-urothelial bladder cancers
    Kipp, B. R.
    Tyner, H. L.
    Campion, M. B.
    Sebo, T. J.
    Halling, K. C.
    Zhang, J.
    MODERN PATHOLOGY, 2008, 21 : 163A - 163A
  • [34] Significance of pigmented urothelial and non-urothelial cells in voided urine specimens: A case report and review
    Kagan, Joseph Alan
    Wu, Susan
    Bardarov, Svetoslav
    JOURNAL OF CYTOLOGY, 2017, 34 (02) : 101 - 103
  • [35] Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer
    Flammia, Rocco Simone
    Chierigo, Francesco
    Wuernschimmel, Christoph
    Wenzel, Mike
    Horlemann, Benedikt
    Tian, Zhen
    Borghesi, Marco
    Leonardo, Costantino
    Tilki, Derya
    Shariat, Shahrokh F.
    Anceschi, Umberto
    Chun, Felix K. H.
    Terrone, Carlo
    Saad, Fred
    Gallucci, Michele
    Karakiewicz, Pierre I.
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2022, 75 (03) : 240 - 247
  • [36] Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities
    Deuker, Marina
    Martin, Thomas
    Stolzenbach, Franziska
    Rosiello, Giuseppe
    Ruvolo, Claudia Colla
    Nocera, Luigi
    Tian, Zhe
    Becker, Andreas
    Kluth, Luis
    Roos, Frederik C.
    Tilki, Derya
    Shariat, Shahrokh F.
    Black, Peter C.
    Kassouf, Wassim
    Saad, Fred
    Chun, Felix
    Karakiewicz, Pierre, I
    CLINICAL GENITOURINARY CANCER, 2021, 19 (01) : 60 - +
  • [37] Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study
    Epaillard, Nicolas
    Parent, Pauline
    Loriot, Yohann
    Lavaud, Pernelle
    Vera-Cea, E-B
    Martinez-Chanza, Nieves
    Rodriguez-Vida, Alejo
    Dumont, Clement
    Lozano, Rebeca
    Llacer, Casilda
    Ratta, Raffaele
    Oudard, Stephane
    Thibault, Constance
    Auclin, Edouard
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] Outcome of partial cystectomy for non-urothelial urinary bladder malignancies in A Tertiary Care Urology Unit in Sri Lanka: a case series
    Jayarajah, U.
    Herath, K.
    Fernando, H.
    Goonewardena, S.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 159 - 159
  • [39] Chemotherapy with significant mortality benefit in patients with bladder cancer with variant and non-urothelial histologies (NUVH).
    Perimbeti, Stuthi
    Jiang, Changchuan
    Deng, Lei
    Roy, Arya Mariam
    Gupta, Shilpi
    Kambam, Greeshma
    Chatta, Gurkamal S.
    George, Saby
    Gopalakrishnan, Dharmesh
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Incidence and characterization of pure non-urothelial bladder and upper tract cancers: A 10-year review
    Gupta, Kanika
    El Bahesh, Ehab
    Finianos, Antoine Nafez
    Clark, Brandon
    Simmens, Samuel
    Aragon-Ching, Jeanny B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)